The role of endothelial cells and their progenitors in intimal hyperplasia

Therapeutic Advances in Cardiovascular Disease

Volumn 4, Issue 2, 2010, Pages 129-141

  Patel, S D ^a   Waltham, M ^a   Wadoodi, A ^a   Burnand, K G ^a   Smith, A ^b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Endothelial function; Endothelial progenitor cell; Intimal hyperplasia; Restenosis

Indexed keywords

ARTERY INTIMA PROLIFERATION; BONE MARROW; CARDIOVASCULAR RISK; CELL COUNT; CELL FUNCTION; CELL PROLIFERATION; DRUG ELUTING STENT; ENDOTHELIUM CELL; ENDOTHELIUM PROGENITOR CELL; HEART INFARCTION; HUMAN; INFLAMMATION; MESENCHYMAL STEM CELL; MONOCYTE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RESTENOSIS; REVIEW; RISK REDUCTION; SMOOTH MUSCLE FIBER; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; STENT THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANIMALS; CARDIOVASCULAR DISEASES; CORONARY RESTENOSIS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; HYPERPLASIA; STEM CELL TRANSPLANTATION; STEM CELLS; TUNICA INTIMA;

EID: 77950493083     PISSN: 17539447     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753944710362903     Document Type: Review

References (137)

1. Aicher, A., Heeschen, C., Mildner-Rihm, C., Urbich, C., Ihling, C., Technau-Ihling, K. et al. (2003) Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9: 1370-1376.
2. Aoki, J., Serruys, P.W., van Beusekom, H., Ong, A.T., McFadden, E.P., Sianos, G. et al. (2005) Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy
3. Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J Am Coll Cardiol 45: 1574-1579.
4. Asahara, T., Bauters, C., Pastore, C., Kearney, M., Rossow, S., Bunting, S. et al. (1995) Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 91: 2793-2801.
5. Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M. et al. (1999 a) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-228.
6. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T. et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.
7. Asahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H. et al. (1999 b) VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18: 3964-3972.
8. Ascher, E., Gade, P., Hingorani, A., Mazzariol, F., Gunduz, Y., Fodera, M. et al. (2000) Changes in the practice of angioaccess surgery: impact of dialysis outcome and quality initiative recommendations. J Vasc Surg 31: 84-92.
9. Autiero, M., Luttun, A., Tjwa, M. and Carmeliet, P. ( 2003) Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J Thromb Haemost 1: 1356-1370.
10. Banerjee, S., Brilakis, E., Zhang, S., Roesle, M., Lindsey, J., Philips, B. et al. (2006) Endothelial progenitor cell mobilization after percutaneous coronary intervention. Atherosclerosis 189: 70-75.
11. Barleon, B., Sozzani, S., Zhou, D., Weich, H.A., Mantovani, A. and Marme, D. ( 1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87: 3336-3343.
12. Bath, P.M., Hassall, D.G., Gladwin, A.M., Palmer, R.M. and Martin, J.F. ( 1991) Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler Thromb 11: 254-260.
13. Beltrami, A.P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S. et al. (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763-776.
14. Bonetti, P.O., Lerman, L.O. and Lerman, A. ( 2003) Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23: 168-175.
15. Burger, P.E., Coetzee, S., McKeehan, W.L., Kan, M., Cook, P., Fan, Y. et al. (2002) Fibroblast growth factor receptor-1 is expressed by endothelial progenitor cells. Blood 100: 3527-3535.
16. Case, J., Mead, L.E., Bessler, W.K., Prater, D., White, H.A., Saadatzadeh, M.R. et al. (2007) Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 35: 1109-1118.
17. Celermajer, D.S., Sorensen, K.E., Bull, C., Robinson, J. and Deanfield, J.E. ( 1994) Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 24: 1468-1474.
18. Chen, J.Z., Zhang, F.R., Tao, Q.M., Wang, X.X., Zhu, J.H. and Zhu, J.H. ( 2004) Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. Clin Sci (Lond) 107: 273-280.
19. Cho, H.J., Kim, H.S., Lee, M.M., Kim, D.H., Yang, H.J., Hur, J. et al. (2003) Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation. Circulation 108: 2918-2925.
20. Cipollone, F., Marini, M., Fazia, M., Pini, B., Iezzi, A., Reale, M. et al. (2001) Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 21: 327-334.
21. Clowes, A.W. and Karnowsky, M.J. ( 1977) Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 265: 625-626.
22. Co, M., Tay, E., Lee, C.H., Poh, K.K., Low, A., Lim, J. et al. (2008) Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: intermediate- to long-term clinical follow-up. Am Heart J 155: 128-132.
23. Corson, J.D., Leather, R.P., Balko, A., Naraynsingh, V., Karmody, A.M. and Shah, D.M. ( 1985) Relationship between vasa vasorum and blood flow to vein bypass endothelial morphology. Arch Surg 120: 386-388.
24. Costa, M.A. and Simon, D.I. ( 2005) Molecular basis of restenosis and drug-eluting stents. Circulation 111: 2257-2273.
25. De, F.E., Porcelli, D., Torella, A.R., Straino, S., Iachininoto, M.G., Orlandi, A. et al. (2004) SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 104: 3472-3482.
26. de Ruiter, M.C., Poelmann, R.E., VanMunsteren, J.C., Mironov, V., Markwald, R.R. and Gittenbergerde Groot, A.C. ( 1997) Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ Res 80: 444-451.
27. Dimmeler, S. and Leri, A. ( 2008) Aging and disease as modifiers of efficacy of cell therapy. Circ Res 102: 1319-1330.
28. Duckers, H.J., Silber, S., de Winter, R., den Heijer, P., Rensing, B., Rau, M. et al. (2007 a) Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent. EuroIntervention 3: 67-75.
29. Duckers, H.J., Soullie, T., den Heijer, P., Rensing, B., de Winter, R.J., Rau, M. et al. (2007 b) Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent). EuroIntervention 3: 350-358.
30. Farb, A., Kolodgie, F.D., Hwang, J.Y., Burke, A.P., Tefera, K., Weber, D.K. et al. (2004) Extracellular matrix changes in stented human coronary arteries. Circulation 110: 940-947.
31. Fernandez, P.B., Lucibello, F.C., Gehling, U.M., Lindemann, K., Weidner, N., Zuzarte, M.L. et al. (2000) Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 65: 287-300.
32. Forrester, J.S., Fishbein, M., Helfant, R. and Fagin, J. ( 1991) A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J Am Coll Cardiol 17: 758-769.
33. Frericks, H., Kievit, J., van Baalen, J.M. and van Bockel, J.H. ( 1998) Carotid recurrent stenosis and risk of ipsilateral stroke: a systematic review of the literature. Stroke 29: 244-250.
34. Fujiyama, S., Amano, K., Uehira, K., Yoshida, M., Nishiwaki, Y., Nozawa, Y. et al. (2003) Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res 93: 980-989.
35. Furukawa, Y., Matsumori, A., Ohashi, N., Shioi, T., Ono, K., Harada, A. et al. (1999) Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries. Circ Res 84: 306-314.
36. George, J., Herz, I., Goldstein, E., Abashidze, S., Deutch, V., Finkelstein, A. et al. (2003) Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arterioscler Thromb Vasc Biol 23: e57-e60.
37. George, J., Shmilovich, H., Deutsch, V., Miller, H., Keren, G. and Roth, A. ( 2006) Comparative analysis of methods for assessment of circulating endothelial progenitor cells. Tissue Eng 12: 331-335.
38. Gill, M., Dias, S., Hattori, K., Rivera, M.L., Hicklin, D., Witte, L. et al. (2001) Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 88: 167-174.
39. Goldman, S., Zadina, K., Moritz, T., Ovitt, T., Sethi, G., Copeland, J.G. et al. (2004) Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol 44: 2149-2156.
40. Gronthos, S., Franklin, D.M., Leddy, H.A., Robey, P.G., Storms, R.W. and Gimble, J.M. ( 2001) Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 189: 54-63.
41. Groschel, K., Riecker, A., Schulz, J.B., Ernemann, U. and Kastrup, A. ( 2005) Systematic review of early recurrent stenosis after carotid angioplasty and stenting. Stroke 36: 367-373.
42. Hedman, M., Hartikainen, J., Syvanne, M., Stjernvall, J., Hedman, A., Kivela, A. et al. (2003) Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 107: 2677-2683.
43. Heiss, C., Keymel, S., Niesler, U., Ziemann, J., Kelm, M. and Kalka, C. ( 2005) Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 45: 1441-1448.
44. Hibbert, B., Chen, Y.X. and O'Brien, E.R. ( 2004) C-kit-immunopositive vascular progenitor cells populate human coronary in-stent restenosis but not primary atherosclerotic lesions. Am J Physiol Heart Circ Physiol 287: H518-H524.
45. Hill, J.M., Zalos, G., Halcox, J.P., Schenke, W.H., Waclawiw, M.A., Quyyumi, A.A. et al. (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600.
46. Hiltunen, M.O., Laitinen, M., Turunen, M.P., Jeltsch, M., Hartikainen, J., Rissanen, T.T. et al. (2000) Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation 102: 2262-2268.
47. Horvath, C., Welt, F.G., Nedelman, M., Rao, P. and Rogers, C. ( 2002) Targeting CCR 2 or CD18 inhibits experimental in-stent restenosis in primates: inhibitory potential depends on type of injury and leukocytes targeted. Circ Res 90: 488-494.
48. Hu, Y., Davison, F., Ludewig, B., Erdel, M., Mayr, M., Url, M. et al. (2002 a) Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells. Circulation 106: 1834-1839.
49. Hu, Y., Davison, F., Zhang, Z. and Xu, Q. ( 2003) Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells. Circulation 108: 3122-3127.
50. Hu, Y., Mayr, M., Metzler, B., Erdel, M., Davison, F. and Xu, Q. ( 2002b) Both donor and recipient origins of smooth muscle cells in vein graft atherosclerotic lesions. Circ Res 91: e13-e20.
51. Hu, Y., Zhang, Z., Torsney, E., Afzal, A.R., Davison, F., Metzler, B. et al. (2004) Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest 113: 1258-1265.
52. Hur, J., Yoon, C.H., Kim, H.S., Choi, J.H., Kang, H.J., Hwang, K.K. et al. (2004) Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24: 288-293.
53. Ingram, D.A., Mead, L.E., Tanaka, H., Meade, V., Fenoglio, A., Mortell, K. et al. (2004) Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104: 2752-2760.
54. Ishiwata, S., Tukada, T., Nakanishi, S., Nishiyama, S. and Seki, A. ( 1997) Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis. Am Heart J 133: 387-392.
55. Ishizawa, K., Kubo, H., Yamada, M., Kobayashi, S., Suzuki, T., Mizuno, S. et al. (2004) Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cells. Biochem Biophys Res Commun 324: 276-280.
56. Jackson, K.A., Majka, S.M., Wang, H., Pocius, J., Hartley, C.J., Majesky, M.W. et al. (2001) Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107: 1395-1402.
57. Jackson, K.A., Mi, T. and Goodell, M.A. ( 1999) Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci U S A 96: 14482-14486.
58. Jankowski, R.J., Deasy, B.M. and Huard, J. ( 2002) Muscle-derived stem cells. Gene Ther 9: 642-647.
59. Kang, H.J., Kim, H.S., Zhang, S.Y., Park, K.W., Cho, H.J., Koo, B.K. et al. (2004) Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363: 751-756.
60. Kashiwakura, Y., Katoh, Y., Tamayose, K., Konishi, H., Takaya, N., Yuhara, S. et al. (2003) Isolation of bone marrow stromal cell-derived smooth muscle cells by a human SM22alpha promoter: in vitro differentiation of putative smooth muscle progenitor cells of bone marrow. Circulation 107: 2078-2081.
61. Kearney, M., Pieczek, A., Haley, L., Losordo, D.W., Andres, V., Schainfeld, R. et al. (1997) Histopathology of in-stent restenosis in patients with peripheral artery disease. Circulation 95: 1998-2002.
62. Kennedy, J.H., Lever, M.J., Addis, B.J. and Paneth, M. ( 1989) Changes in vein interstitium following distension for aortocoronary bypass. J Cardiovasc Surg ( Torino) 30: 992-995.
63. Khakoo, A.Y. and Finkel, T. ( 2005) Endothelial progenitor cells. Annu Rev Med 56: 79-101.
64. Kim, I., Moon, S.O., Kim, S.H., Kim, H.J., Koh, Y.S. and Koh, G.Y. ( 2001) Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 276: 7614-7620.
65. Kinnaird, T., Stabile, E., Burnett, M.S., Shou, M., Lee, C.W., Barr, S. et al. (2004) Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109: 1543-1549.
66. Kitta, Y., Nakamura, T., Kodama, Y., Takano, H., Umetani, K., Fujioka, D. et al. (2005) Endothelial vasomotor dysfunction in the brachial artery is associated with late in-stent coronary restenosis. J Am Coll Cardiol 46: 648-655.
67. Klomp, M., Beijk, M.A., Verouden, N.J., Tijssen, J.G. and de Winter, R.J. (2009) Design and rationale of the TRI-stent adjudication study (TRIAS) program. Am Heart J 158: 527-532.
68. Kondo, T., Hayashi, M., Takeshita, K., Numaguchi, Y., Kobayashi, K., Iino, S. et al. (2004) Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 24: 1442-1447.
69. Kong, D., Melo, L.G., Gnecchi, M., Zhang, L., Mostoslavsky, G., Liew, C.C. et al. (2004 a) Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 110: 2039-2046.
70. Kong, D., Melo, L.G., Mangi, A.A., Zhang, L., Lopez-Ilasaca, M., Perrella, M.A. et al. (2004 b) Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 109: 1769-1775.
71. Kwon, H.M., Sangiorgi, G., Ritman, E.L., Lerman, A., McKenna, C., Virmani, R. et al. (1998) Adventitial vasa vasorum in balloon-injured coronary arteries: visualization and quantitation by a microscopic three-dimensional computed tomography technique. J Am Coll Cardiol 32: 2072-2079.
72. Landmesser, U., Hornig, B. and Drexler, H. ( 2004) Endothelial function: a critical determinant in atherosclerosis? Circulation 109: 1127-1133.
73. Lattimer, C.R. and Burnand, K.G. ( 1997) Recurrent carotid stenosis after carotid endarterectomy. Br J Surg 84: 1206-1219.
74. Laufs, U., Werner, N., Link, A., Endres, M., Wassmann, S., Jurgens, K. et al. (2004) Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 109: 220-226.
75. Li, B., Sharpe, E.E., Maupin, A.B., Teleron, A.A., Pyle, A.L., Carmeliet, P. et al. (2006) VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J 20: 1495-1497.
76. Lindner, V., Olson, N.E., Clowes, A.W. and Reidy, M.A. ( 1992) Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor. J Clin Invest 90: 2044-2049.
77. Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L. et al. (2001) Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 7: 1194-1201.
78. Mann, J.M., McIntosh, C.L. and Roberts, W.C. ( 1987) Spasm of saphenous veins used as conduits for aortocoronary bypass grafting. Am J Cardiol 59: 1000-1002.
79. Marek, J.M., Koehler, C., Aguirre, M.L., Westerband, A., Gentile, A.T., Mills, J.L. et al. (1998) The histologic characteristics of primary and restenotic carotid plaque. J Surg Res 74: 27-33.
80. Marumo, T., Schini-Kerth, V.B. and Busse, R. ( 1999) Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 48: 1131-1137.
81. Matsuo, Y., Imanishi, T., Hayashi, Y., Tomobuchi, Y., Kubo, T., Hano, T. et al. (2006) The effect of senescence of endothelial progenitor cells on in-stent restenosis in patients undergoing coronary stenting. Intern Med 45: 581-587.
82. McEver, R.P. and Cummings, R.D. ( 1997) Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest 100: S97-S103.
83. Miglionico, M., Patti, G., D'Ambrosio, A. and Di, S.G. ( 2008) Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients. Catheter Cardiovasc Interv 71: 600-604.
84. Moore, M.A., Hattori, K., Heissig, B., Shieh, J.H., Dias, S., Crystal, R.G. et al. (2001) Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. Ann N Y Acad Sci 938: 36-45.
85. Muradin, G.S., Bosch, J.L., Stijnen, T. and Hunink, M.G. ( 2001) Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology 221: 137-145.
86. Nagaya, N., Fujii, T., Iwase, T., Ohgushi, H., Itoh, T., Uematsu, M. et al. (2004) Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol 287: H2670-H2676.
87. Noort, W.A., Kruisselbrink, A.B., in't Anker, P.S., Kruger, M., van Bezooijen, R.L., de Paus, R.A. et al. (2002) Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD / SCID mice. Exp Hematol 30: 870-878.
88. O'Brien, E.R., Garvin, M.R., Dev, R., Stewart, D.K., Hinohara, T., Simpson, J.B. et al. (1994) Angiogenesis in human coronary atherosclerotic plaques. Am J Pathol 145: 883-894.
89. Orlic, D., Kajstura, J., Chimenti, S., Limana, F., Jakoniuk, I., Quaini, F. et al. (2001) Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 98: 10344-10349.
90. Oswald, J., Boxberger, S., Jorgensen, B., Feldmann, S., Ehninger, G., Bornhauser, M. et al. (2004) Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22: 377-384.
91. Patti, G., Pasceri, V., Melfi, R., Goffredo, C., Chello, M., D'Ambrosio, A. et al. (2005) Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation. Circulation 111: 70-75.
92. Peters, K.G., de Vries, C. and Williams, L.T. (1993) Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci U S A 90: 8915-8919.
93. Rehman, J., Li, J., Orschell, C.M. and March, K.L. ( 2003) Peripheral blood “endothelial progenitor cells” are derived from monocyte / macrophages and secrete angiogenic growth factors. Circulation 107: 1164-1169.
94. Reyes, M., Dudek, A., Jahagirdar, B., Koodie, L., Marker, P.H. and Verfaillie, C.M. ( 2002) Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109: 337-346.
95. Roberts, N., Xiao, Q., Weir, G., Xu, Q. and Jahangiri, M. ( 2007) Endothelial progenitor cells are mobilized after cardiac surgery. Ann Thorac Surg 83: 598-605.
96. Rohde, E., Malischnik, C., Thaler, D., Maierhofer, T., Linkesch, W., Lanzer, G. et al. (2006) Blood monocytes mimic endothelial progenitor cells. Stem Cells 24: 357-367.
97. Roiron, C., Sanchez, P., Bouzamondo, A., Lechat, P. and Montalescot, G. ( 2006) Drug-eluting stents: a meta-analysis of randomised controlled trials. Heart 92 (5): 641-649.
98. Roque, M., Kim, W.J., Gazdoin, M., Malik, A., Reis, E.D., Fallon, J.T. et al. (2002) CCR 2 deficiency decreases intimal hyperplasia after arterial injury. Arterioscler Thromb Vasc Biol 22: 554-559.
99. Ross, R. ( 1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809.
100. Rossi, M.L., Zavalloni, D., Gasparini, G.L., Mango, R., Belli, G. and Presbitero, P. ( 2009) The first report of late stent thrombosis leading to acute myocardial infarction in patient receiving the new endothelial progenitor cell capture stent. Int J Cardiol Jan 8 [Epub ahead of print].
101. Roufosse, C.A., Direkze, N.C., Otto, W.R. and Wright, N.A. ( 2004) Circulating mesenchymal stem cells. Int J Biochem Cell Biol 36: 585-597.
102. Ryan, J. and Cohen, D.J. ( 2006) Are drug-eluting stents cost-effective? It depends on whom you ask. Circulation 114: 1736-1743.
103. Saiura, A., Sata, M., Hirata, Y., Nagai, R. and Makuuchi, M. ( 2001) Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med 7: 382-383.
104. Sandri, M., Adams, V., Gielen, S., Linke, A., Lenk, K., Krankel, N. et al. (2005) Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies. Circulation 111: 3391-3399.
105. Sata, M., Saiura, A., Kunisato, A., Tojo, A., Okada, S., Tokuhisa, T. et al. (2002) Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8: 403-409.
106. Schmidt-Lucke, C., Rossig, L., Fichtlscherer, S., Vasa, M., Britten, M., Kamper, U. et al. (2005) Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111: 2981-2987.
107. Shintani, S., Murohara, T., Ikeda, H., Ueno, T., Honma, T., Katoh, A. et al. (2001) Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103: 2776-2779.
108. Shoji, M., Sata, M., Fukuda, D., Tanaka, K., Sato, T., Iso, Y. et al. (2004) Temporal and spatial characterization of cellular constituents during neointimal hyperplasia after vascular injury: Potential contribution of bone-marrow-derived progenitors to arterial remodeling. Cardiovasc Pathol 13: 306-312.
109. Simper, D., Stalboerger, P.G., Panetta, C.J., Wang, S. and Caplice, N.M. ( 2002) Smooth muscle progenitor cells in human blood. Circulation 106: 1199-1204.
110. Smith, S.H. and Geer, J.C. ( 1983) Morphology of saphenous vein-coronary artery bypass grafts: Seven to 116 months after surgery. Arch Pathol Lab Med 107: 13-18.
111. Snow, A.D., Bolender, R.P., Wight, T.N. and Clowes, A.W. ( 1990) Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells. Am J Pathol 137: 313-330.
112. Strauss, B.H., Chisholm, R.J., Keeley, F.W., Gotlieb, A.I., Logan, R.A. and Armstrong, P.W. ( 1994) Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 75: 650-658.
113. Takahashi, T., Kalka, C., Masuda, H., Chen, D., Silver, M., Kearney, M. et al. (1999) Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5: 434-438.
114. Takamiya, M., Okigaki, M., Jin, D., Takai, S., Nozawa, Y., Adachi, Y. et al. (2006) Granulocyte colony-stimulating factor-mobilized circulating c-Kit+/ Flk-1+ progenitor cells regenerate endothelium and inhibit neointimal hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol 26: 751-757.
115. Tang, Y.L., Zhao, Q., Zhang, Y.C., Cheng, L., Liu, M., Shi, J. et al. (2004) Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul Pept 117: 3-10.
116. Tepper, O.M., Galiano, R.D., Capla, J.M., Kalka, C., Gagne, P.J., Jacobowitz, G.R. et al. (2002) Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106: 2781-2786.
117. Timmermans, F., Plum, J., Yoder, M.C., Ingram, D.A., Vandekerckhove, B. and Case, J. (2009) Endothelial progenitor cells: identity defined? J Cell Mol Med 13: 87-102.
118. Tuli, R., Seghatoleslami, M.R., Tuli, S., Wang, M.L., Hozack, W.J., Manner, P.A. et al. (2003) A simple, high-yield method for obtaining multipotential mesenchymal progenitor cells from trabecular bone. Mol Biotechnol 23: 37-49.
119. Urbich, C. and Dimmeler, S. ( 2004) Endothelial progenitor cells functional characterization. Trends Cardiovasc Med 14: 318-322.
120. Urbich, C., Heeschen, C., Aicher, A., Dernbach, E., Zeiher, A.M. and Dimmeler, S. ( 2003) Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108: 2511-2516.
121. Valina, C., Pinkernell, K., Song, Y.H., Bai, X., Sadat, S., Campeau, R.J. et al. (2007) Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur Heart J 28: 2667-2677.
122. Vasa, M., Fichtlscherer, S., Aicher, A., Adler, K., Urbich, C., Martin, H. et al. (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89: E1-E7.
123. Verma, S., Buchanan, M.R. and Anderson, T.J. ( 2003) Endothelial function testing as a biomarker of vascular disease. Circulation 108: 2054-2059.
124. Walter, D.H., Cejna, M., az-Sandoval, L., Willis, S., Kirkwood, L., Stratford, P.W. et al. (2004) Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis. Circulation 110: 36-45.
125. Walter, D.H., Rittig, K., Bahlmann, F.H., Kirchmair, R., Silver, M., Murayama, T. et al. (2002) Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105: 3017-3024.
126. Wang, T., Xu, Z., Jiang, W. and Ma, A. ( 2006) Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell. Int J Cardiol 109 (1): 74-81.
127. Weaver, W.D., Reisman, M.A., Griffin, J.J., Buller, C.E., Leimgruber, P.P., Henry, T. et al. (2000) Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): a randomised trial. Lancet 355: 2199-2203.
128. Welt, F.G. and Rogers, C. ( 2002) Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 22: 1769-1776.
129. Werner, N., Junk, S., Laufs, U., Link, A., Walenta, K., Bohm, M. et al. (2003) Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 93: e17-e24.
130. Werner, N., Priller, J., Laufs, U., Endres, M., Bohm, M., Dirnagl, U. et al. (2002) Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase
131. inhibition. Arterioscler Thromb Vasc Biol 22: 1567-1572.
132. Widlansky, M.E., Gokce, N., Keaney, Jr J.F. and Vita, J.A. ( 2003) The clinical implications of endothelial dysfunction. J Am Coll Cardiol 42: 1149-1160.
133. Wight, T.N. ( 1989) Cell biology of arterial proteoglycans. Arteriosclerosis 9: 1-20.
134. Xu, Q., Zhang, Z., Davison, F. and Hu, Y. ( 2003) Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice. Circ Res 93: e76-e86.
135. Yamaguchi, J., Kusano, K.F., Masuo, O., Kawamoto, A., Silver, M., Murasawa, S. et al. (2003) Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107: 1322-1328.
136. Yoder, M.C., Mead, L.E., Prater, D., Krier, T.R., Mroueh, K.N., Li, F. et al. (2007) Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem / progenitor cell principals. Blood 109: 1801-1809.
137. Zernecke, A., Schober, A., Bot, I., von Hundelshausen, P., Liehn, E.A., Mopps, B. et al. (2005) SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ Res 96: 784-791.